Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders

Stefka Krumova1, Ivona Andonova1, Radostina Stefanova1

  • 1National Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.

Insights

Primate erythroparvovirus 1 (B19V) frequently infects patients with hematological disorders. Testing for B19V DNA and antibodies is crucial for accurate diagnosis and management in these vulnerable individuals.

Area of Science:

  • Virology
  • Hematology
  • Immunology

Background:

  • Primate erythroparvovirus 1 (B19V) causes erythema infectiosum and can lead to persistent anemia, especially in immunocompromised individuals.
  • Dialysis patients are susceptible to B19V-induced anemia.

Purpose of the Study:

  • To investigate the prevalence of B19V infections in patients with hematological disorders.
  • To assess the diagnostic utility of B19V DNA and antibody testing in this patient group.

Main Methods:

  • Laboratory investigation of 21 patients with hematological disorders for B19V.
  • Detection of B19V DNA and specific IgM antibodies.
  • Genotyping of B19V DNA sequences.
  • Laboratory monitoring of infected patients over one year.

Main Results:

  • B19V DNA was detected in 13 (62%) of the patients.
  • Three patients tested positive for specific IgM antibodies.
  • Persistent B19V infection markers were found in only two patients after one year.
  • Sequences from four samples clustered with B19V genotype 1a.

Conclusions:

  • B19V infection is common in patients with hematological disorders.
  • Routine screening for B19V DNA and antibodies is recommended for accurate diagnosis and management.
  • Most B19V infections in this cohort resolved within a year.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.9K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.7K